tirzepatide vs semaglutide compound Semaglutide: Key Differences how to choose between semaglutide

The cumulative incidence rates of NAION for the semaglutide and nonGLP-1 RA cohorts over 36 months were 8.9% (95% confidence interval [CI], 4.5%-13.1%) and 1.8% (95% CI, 0%-3.5%), respectively. The analysis showed that patients treated with semaglutide had a higher risk of developing NAION compared with non-GLP-1 RA antidiabetes medications (hazard ratio [HR], 4.28

Practical principles include: Begin slowly, especially in spring or after long indoor periods Use shorter exposures around solar noon when vitamin D production is most efficient Expose larger skin areas for shorter durations rather than small areas for long periods Stop exposure or cover up before any sign of erythema develops Check the skin several hours later since redness may appear after exposure Protecting the Head While Exposing the Body One particularly interesting recommendation from traditional heliotherapy approaches is keeping the head cool and shaded while exposing larger body areas

Read my review here

Este primer agonista de GLP-1 se empleaba para tratar la diabetes, pero los estudios desvelaron un efecto secundario muy interesante: prdida de peso

Avoid using Wegovy to undereat Very low intake can contribute to weakness, fatigue, constipation, nutrient deficiency, gallstones and muscle loss